Benliro, Shirly T.
HRN: 24-30-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/02/2024
01/08/2024
IVT
2.25g
Q6
CAP MR; Complicated UTI; S/p CTT R
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes